← Leaderboards
Simon M Barratt-Boyes
University Of Pittsburgh At Pittsburgh
$10,547,684
Attributed
$11,712,873
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $847.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,712,873 · 8
By mechanism
R01$10,118,965 · 3
R21$826,545 · 1
T32$451,182 · 1
P01$213,937 · 2
K01$102,244 · 1
Top collaborators
- Yuan Liu3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Andrew J Nowalk$407,820
- Cristian Apetrei$24,938,676
- Anuradha Ray$26,369,891
- Amy L Hartman$17,863,276
- Melanie J. Scott$5,742,375
Others in their field
Top investigators on “Virus Diseases”
- Barton F Haynes · Duke University$305,832,186
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Lawrence Corey · Fred Hutchinson Cancer Center$271,990,515
- Richard Webby · St. Jude Children'S Research Hospital$264,105,723
- David Heimbrook · Leidos Biomedical Research, Inc.$262,417,885
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$252,117,999
Research focus
Virus DiseasesDendritic CellsCellsInfectionMediatingVirusMacaca MulattaAntiviral AgentsImmune ResponseCytokinePlayBloodInterferonsAcquired Immunodeficiency SyndromeImmuneInflammationPathogenesisTissuesInflammatoryFlow CytometryCd4 Positive T LymphocytesChronicApoptosisLymph Nodes
Grant awards (29)
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome$779,817
R01 · FY2025 · AI
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome$785,479
R01 · FY2024 · AI
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome$765,082
R01 · FY2023 · AI
Immunity to Live Mosquito Probing and Flavivirus Infection in Human Skin$293,034
R21 · FY2020 · AI · contact PI
Immunity to Live Mosquito Probing and Flavivirus Infection in Human Skin$235,559
R21 · FY2020 · AI · contact PI
PITT AIDS Research Training Program$231,132
T32 · FY2020 · AI · contact PI
Blocking pyroptosis to prevent acute lung injury in SARS-CoV-2 infection$87,402
R21 · FY2020 · AI · contact PI
PITT AIDS Research Training Program$220,050
T32 · FY2019 · AI · contact PI
Immunity to Live Mosquito Probing and Flavivirus Infection in Human Skin$210,550
R21 · FY2019 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$702,901
R01 · FY2016 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$684,284
R01 · FY2015 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$693,284
R01 · FY2014 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$640,225
R01 · FY2013 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$684,191
R01 · FY2012 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$491,783
R01 · FY2011 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$514,146
R01 · FY2010 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$495,640
R01 · FY2009 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$167,810
R01 · FY2009 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$469,430
R01 · FY2008 · AI · contact PI
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection$455,363
R01 · FY2007 · AI · contact PI
Whole Autologous SIV Vaccine Using Dendritic Cells$349,777
R01 · FY2006 · AI · contact PI
Whole Autologous SIV Vaccine Using Dendritic Cells$360,057
R01 · FY2005 · AI
Whole Autologous SIV Vaccine Using Dendritic Cells$360,669
R01 · FY2004 · AI
Whole Autologous SIV Vaccine Using Dendritic Cells$359,337
R01 · FY2003 · AI
Whole Autologous SIV Vaccine Using Dendritic Cells$359,690
R01 · FY2002 · AI
DENDRITIC CELL BASED ADJUVANT THERAPY FOR HIV--SIV MODEL$0
P01 · FY2001 · AI
DENDRITIC CELL ROLE IN ADJUVANT DNA VACCINES$0
P01 · FY2001 · AI
DENDRITIC CELL BASED ADJUVANT THERAPY FOR HIV--SIV MODEL$213,937
P01 · FY2000 · AI
PRIMATE MODEL OF DENDRITIC CELL-BASED IMMUNOTHERAPY$102,244
K01 · FY2000 · RR